Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
about
Crystal structure of mouse RhoA:GTPγS complex in a centered latticeDepletion of PtdIns(4,5)P₂ underlies retinal degeneration in Drosophila trp mutants.PLCε, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart.Whole transcriptome analysis of the fasting and fed Burmese python heart: insights into extreme physiological cardiac adaptationRho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.Rho-kinase in development and heart failure: insights from genetic modelsRho kinase as a therapeutic target in cardiovascular disease.Microdomain heterogeneity in 3D affects the mechanics of neonatal cardiac myocyte contraction.Endurance training in early life results in long-term programming of heart mass in ratsRhoGEF12 controls cardiac remodeling by integrating G protein- and integrin-dependent signaling cascades.Dissecting the roles of ROCK isoforms in stress-induced cell detachment.Nutrient-sensing mTORC1: Integration of metabolic and autophagic signalsDistinct roles for ROCK1 and ROCK2 in the regulation of cell detachment.A ROCK Inhibitor Blocks the Inhibitory Effect of Chondroitin Sulfate Proteoglycan on Morphological Changes of Mesenchymal Stromal/Stem Cells into Neuron-Like Cells.Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function.Lysophospholipid receptor activation of RhoA and lipid signaling pathways.Rho-kinase: regulation, (dys)function, and inhibition.Structure of giant muscle proteins.The sarcomeric M-region: a molecular command center for diverse cellular processes.How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.RhoA protects the mouse heart against ischemia/reperfusion injuryRosuvastatin inhibits the smooth muscle cell proliferation by targeting TNFα mediated Rho kinase pathway.Hypoxic induction of T-type Ca(2+) channels in rat cardiac myocytes: role of HIF-1α and RhoA/ROCK signalling.Enhancement of endothelial progenitor cell numbers and migration by H1152, a Rho kinase specific inhibitor.
P2860
Q27682445-5ECEAE30-CE37-43EB-A564-6D9D66B266B4Q30539164-5E6CDE9A-29E4-464F-8168-C25B5C442863Q33670240-E35825B6-3996-4DB1-92DD-2D3B85D8F200Q33736492-4917E018-3F54-46AB-87A6-3E0B71285D8FQ34362144-C908B003-5CB8-4939-9F7B-82B80C0C9C90Q34893701-58549F6C-C774-4E3C-BD91-0635393AA31EQ35352722-5E55103C-B63B-4B24-A43F-E5510CDF4908Q36124189-DFCD4C5B-0E1D-4894-9657-647BE09FC3F2Q36594412-B314F90C-C026-4930-B98C-BF331AE23171Q36750023-788E5BAE-8757-4BA0-8F10-3E783EB1BDCEQ36923317-66C0FF27-AC1F-4B78-8093-284BCAE90DF0Q37008888-0064A20C-1A71-47AE-AE8E-C1B0CC03ACD5Q37073549-EFF7C361-594A-4734-8A93-91C2A837159AQ37429754-4FC27026-4C79-4FE0-B668-7BA2470868AFQ37450106-38BBF196-4F11-4AB8-B545-F230A43A17B4Q37898924-A50F8B0E-3ABE-4A5F-9092-68C8C9D954B2Q38044174-A19E874F-6548-45CA-BCB3-3C40883B715CQ38129373-442D8A6E-1690-465E-85EE-2E32FE039FBFQ38174598-BFA387EC-AB45-486A-9F31-D5696A8E3AFFQ38471353-1F3EEF3F-D6E8-4F7E-B5CC-9F4C2C720617Q38974621-CBDE301E-1595-4ABE-9DD9-F7E4E65BD97AQ42014677-9F8AC175-BBCA-46B3-A825-2DB445243ACAQ42275741-0046259D-A7D5-4642-88C2-3164385323EFQ53359728-C96EA88A-27A0-4219-9B31-3AF59F495DFEQ54537321-7D62A9BC-742B-417F-8E5A-D290719018D8
P2860
Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
@en
Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
@nl
type
label
Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
@en
Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
@nl
prefLabel
Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
@en
Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
@nl
P2093
P2860
P1476
Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
@en
P2093
Dominic P Del Re
Geir Florholmen
Joan Heller Brown
Shigeki Miyamoto
Sunny Y Xiang
P2860
P2888
P304
P356
10.1007/S12265-010-9192-8
P407
P577
2010-05-27T00:00:00Z